Cardiology MCQ Test 2
Time limit: 0 Quiz-summary 0 of 20 questions completed Questions: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ...
Source: Cardiophile MD - October 19, 2017 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs

Brugada syndrome quiz
Short quiz on Brugada syndrome Brugada syndrome quiz Please wait while the activity loads. If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled. If loading fails, click here to try again Congratulations - you have completed Brugada syndrome quiz. You scored %%SCORE%% out of %%TOTAL%%. Your performance has been rated as %%RATING%% Your answers are highlighted below. Question 1Which of the following is not used in provocative testing fo...
Source: Cardiophile MD - December 11, 2016 Category: Cardiology Authors: Prof. Dr. Johnson Francis, MD, DM, FACC, FRCP Edin, FRCP London Tags: Cardiology Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs

MKSAP: 74-year-old woman with peripheral arterial disease
Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 74-year-old woman is evaluated during a routine examination. Her medical history is significant for hypertension and obesity. She is a former smoker, stopping 5 years ago. Medications are amlodipine, lisinopril, and aspirin. On physical examination, she is afebrile, blood pressure is 136/78 mm Hg, pulse rate is 68/min, and respiration rate is 15/min. BMI is 32. The lungs are clear to auscultation, and no murmurs are noted. A bruit is heard over the left femoral artery. The right ankle-brachial index is 1.2 and...
Source: Kevin, M.D. - Medical Weblog - September 3, 2016 Category: Journals (General) Authors: < a href="http://www.kevinmd.com/blog/post-author/mksap" rel="tag" > mksap < /a > Tags: Conditions Heart Source Type: blogs

DM / DNB Cardiology Entrance Mock Test 25
Please wait while the activity loads. If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled. If loading fails, click here to try again Click on the 'Start' button to begin the mock test. After answering all questions, click on the 'Get Results' button to display your score and the explanations. There is no time limit for this mock test. Start Congratulations - you have completed DM / DNB Cardiology Entrance Mock Test 25. You scored %%SCORE%% out of %%TOTAL%%. Your performanc...
Source: Cardiophile MD - April 4, 2016 Category: Cardiology Authors: Prof. Dr. Johnson Francis, MD, DM, FACC, FRCP Edin, FRCP London Tags: Cardiology MCQ DM / DNB Cardiology Entrance Featured Source Type: blogs

Reversible anti-platelet action
While the anti-platelet actions of clopidogrel and prasugrel are irreversible, that of the following drugs are reversible: •Dipyridamole •Cilostazol •NSAIDS (non steroidal anti-inflammatory drugs) •Ticagrelor (Source: Cardiophile MD)
Source: Cardiophile MD - February 22, 2014 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs

Reversible and irreversible platelet inhibition by anti platelet agents
Agents which irreversibly inhibit platelets are: Aspirin Ticlopidine Clopidogrel Prasugrel In general all these agents except prasugrel are ideally discontinued 5 days prior to intended surgery. Prasugrel is better discontinued 7 days prior, because of slightly different pharmacodynamics profile. Agents which reversibly inhibit platelets are: Dipyridamole Cilostazol Nonsteroidal anti-inflammatory drugs Ticagrelor (Source: Cardiophile MD)
Source: Cardiophile MD - January 9, 2014 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs

#184: Rivaroxaban gets ACS indication recommendation from European regulators; MitraClip narrowly passes major test with FDA advisory panel; new oral anticoagulants in secondary stroke prevention: Apples and oranges?; EMA recommends restricting cilostazol
Rivaroxaban gets ACS indication recommendation from European regulators; MitraClip narrowly passes major test with FDA advisory panel; new oral anticoagulants in secondary stroke prevention: Apples and oranges?; EMA recommends restricting cilostazol (Source: Blogs@theHeart.org)
Source: Blogs@theHeart.org - March 28, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: blogs